The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients

被引:0
作者
Anne Flint
Christoph Kapitza
Charlotte Hindsberger
Milan Zdravkovic
机构
[1] Novo Nordisk A/S,
[2] Novo Nordisk A/S,undefined
[3] PROFIL Institut für Stoffwechselforschung GmbH,undefined
来源
Advances in Therapy | 2011年 / 28卷
关键词
exenatide; gastric emptying; incretin; insulin; type 2 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:213 / 226
页数:13
相关论文
共 192 条
[1]  
Gerich J.E.(1998)The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity Endocr Rev 19 491-503
[2]  
Knop F.K.(2007)Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56 1951-1959
[3]  
Vilsbøll T.(1986)Reduced incretin effect in type 2 (non-insulindependent) diabetes Diabetologia 29 46-52
[4]  
Højberg P.V.(1998)Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837-853
[5]  
Nauck M.(2000)Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 405-412
[6]  
Stöckmann F.(2003)Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c) Diabetes Care 26 881-885
[7]  
Ebert R.(2008)Guideline for management of postmeal glucose Nutr Metab Cardiovasc Dis 18 S17-S33
[8]  
Creutzfeldt W.(1964)Plasma insulin responce to oral and intravenous glucose administration J Clin Endocrinol Metab 24 1076-1082
[9]  
Stratton I.M.(1979)The incretin concept today Diabetologia 16 75-85
[10]  
Adler A.I.(2006)Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans Gut 55 243-251